公募基金方面，本期较上一期持股增加的公募基金共计10个，主要包括银华盛泓债券A、易方达中证创 新药产业ETF、创新药、南方中证创新药产业ETF、建信中证创新药产业ETF等，持股增加占比小幅上 涨。本期较上一季度持股减少的公募基金共计8个，主要包括中欧医疗健康混合A、易方达沪深300医药 ETF、华泰柏瑞沪深300ETF、平安中证医疗创新ETF、中信保诚中证800医药指数(LOF)A等，持股减少 占比达0.50%。本期较上一季度新披露的公募基金共计5个，包括富安达优势成长混合A、建信双息红利 债券A、大摩多因子策略混合、银华钰祥债券A、建信兴利灵活配置混合A。本期较上一季未再披露的 公募基金共计633个，主要包括工银前沿医疗股票A、易方达沪深300ETF、华夏沪深300ETF、嘉实沪深 300ETF、广发创新药ETF等。 外资态度来看，本期较上一期持股增加的外资基金共计1个，即香港中央结算有限公司，持股增加占比 达0.69%。 对于社保基金，本期较上一季度持股减少的社保基金共计1个，即全国社保基金一一二组合，，持股减 少占比小幅下跌。 2025年10月28日，华东医药(000963.SZ)发布2025年第三季报 ...

Market Overview - The Shanghai Composite Index decreased by 0.4% to 3351.31 points, with a weekly high of 3394.03 points [1] - The Shenzhen Component Index fell by 0.75% to 10607.33 points, reaching a high of 10745.09 points [1] - The ChiNext Index dropped by 1.12% to 2128.21 points, with a peak of 2165.16 points [1] - Global indices also experienced declines, with the Nasdaq Composite down 2.59%, the Dow Jones Industrial Average down 0.96%, and the S&P 500 down 1.53% [1] ETF Market Performance - The median weekly return for stock ETFs was -0.5% [2] - The highest weekly return among scale index ETFs was 0.87% for the Ping An CSI A50 ETF [2] - The highest return in industry index ETFs was 2.41% for the China Southern CSI Pharmaceutical Health ETF [2] - The top-performing thematic index ETF was the Huatai-PB CSI Hong Kong-Shenzhen Innovative Drug Industry ETF, with a return of 4.1% [2] ETF Liquidity - Average daily trading volume for stock ETFs decreased by 10.5%, while average daily trading volume increased by 0.5% [7] ETF Fund Flows - The top five stock ETFs with the highest inflows included the Jiashi CSI A500 ETF with an inflow of 501 million yuan and the China Southern CSI A500 ETF with an inflow of 426 million yuan [9] - The top five stock ETFs with the highest outflows included the Southern CSI 500 ETF with an outflow of 557 million yuan and the E Fund ChiNext ETF with an outflow of 402 million yuan [10] ETF Financing and Margin Trading - The financing balance for stock ETFs decreased from 45.0861 billion yuan to 44.5767 billion yuan [12] - The highest financing buy amount was 521 million yuan for the Huaxia CSI Sci-Tech 50 ETF [12] ETF Market Size - The total size of the ETF market reached 38,072.59 billion yuan, an increase of 12.028 billion yuan from the previous week [15] - Stock ETFs accounted for 28,371.86 billion yuan, representing the largest category in the ETF market [15] ETF Issuance and Establishment - No new ETFs were issued last week, but 13 new ETFs were established, including the Xinhua CSI A50 ETF and the Huaxia Sci-Tech 50 ETF [18] Institutional Insights - Industrial trends in the innovative drug sector are becoming clearer, with expectations for better development opportunities in China [19] - By 2024, approximately 31% of large multinational pharmaceutical companies are expected to introduce innovative drug candidates from China, indicating a significant market potential for Chinese innovative drugs [19]